Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Rapezzi

Showing results (371-380 of 404) with videos related to

Pageof 41
Sort By:
European Journal of Heart Failure|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
Journal of the American College of Cardiology|July 9, 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)Mathew S Maurer, Mazen Hanna, Martha Grogan, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
Journal of Neurology|August 19, 2021
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosisAlessandro Salvalaggio, Daniele Coraci, Laura Obici, et al.
Circulation|February 8, 2024
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Marco Canepa, et al.
European Journal of Heart Failure|July 20, 2023
State-of-the-art document on optimal contemporary management of cardiomyopathiesPetar M Seferović, Marija Polovina, Giuseppe Rosano, et al.
Circulation|August 6, 2014
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
Circulation. Cardiovascular Imaging|July 1, 2021
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of ImagingSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 2021
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imagingSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 14, 2021
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imagingSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Pageof 41

Showing results (371-380 of 404) with videos related to

Sort By:
Pageof 41
European Journal of Heart Failure|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
Journal of the American College of Cardiology|July 9, 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)Mathew S Maurer, Mazen Hanna, Martha Grogan, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
Journal of Neurology|August 19, 2021
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosisAlessandro Salvalaggio, Daniele Coraci, Laura Obici, et al.
Circulation|February 8, 2024
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Marco Canepa, et al.
European Journal of Heart Failure|July 20, 2023
State-of-the-art document on optimal contemporary management of cardiomyopathiesPetar M Seferović, Marija Polovina, Giuseppe Rosano, et al.
Circulation|August 6, 2014
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
Circulation. Cardiovascular Imaging|July 1, 2021
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of ImagingSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 2021
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imagingSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 14, 2021
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imagingSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Pageof 41